Skip to content
bluejethealthcare.com
Home
About Us
At A Glance
Facilities
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Investor Presentation
Stock Exchange Communication
Financial information
Annual Report
Annual Return
Corporate Governance
Board of Directors
Board Committees
Governance Policies
Familiarization Programmes
Prospectus
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
Menu
Home
About Us
At A Glance
Facilities
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Investor Presentation
Stock Exchange Communication
Financial information
Annual Report
Annual Return
Corporate Governance
Board of Directors
Board Committees
Governance Policies
Familiarization Programmes
Prospectus
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
Shareholding Pattern
2023-2024
Q4 Trading Window Closure
Q3 Newspaper advertisement for Financials BM
Shareholding Pattern PreListing
Shareholding pattern Q3
Scroll to Top
